NASDAQ$ALHC
Alignment Healthcare Inc · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Reported strong Q4 2021 financial results, highlighting the effectiveness of their clinical model and AVA® platform.
Alignment Healthcare reported strong fourth-quarter results, driven by their clinical model and proprietary AVA® platform. The company is focused on investing in new markets and scaling their differentiated model in 2022.
- Strong fourth-quarter results across critical KPIs.
- Success showcased the power of their clinical model.
- Proprietary AVA® platform to deliver steady growth.
- Effective medical benefits ratio.
Headline financials
Revenue & EPS history
Alignment Healthcare · Revenue · Quarterly
$298M
Revenue by segment
Alignment Healthcare · $265M total across 2 segments · Q1 2021
- Earned premiums$265M+18.0%100.0%
- Other revenue$82K—0.0%
Forward guidance
The release contains forward-looking statements regarding future growth and financial outlook for the first quarter ending March 31, 2022, and year ending Dec. 31, 2022.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2021
+1.8%
Avg return
Earnings day
+1.8%
Avg return
5 days after
+2.6%
Avg return
30 days after
57%
12 / 21 earnings
Positive
+27.0%
Q1 2024
Best reaction
-16.4%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.8% | -15.7% | -29.5% | |
| Q4 2025 | -5.8% | -7.5% | -18.6% | |
| Q3 2025 | -1.9% | -0.4% | +12.2% | |
| Q1 2025 | -7.7% | -7.5% | -8.3% | |
| Q4 2024 | +16.5% | +17.4% | +35.9% | |
| Q3 2024 | +1.6% | +12.2% | +11.2% | |
| Q2 2024 | +2.3% | +4.9% | +3.1% | |
| Q1 2024 | +27.0% | +31.6% | +51.0% | |
| Q4 2023 | -8.9% | -9.2% | -20.1% | |
| Q3 2023 | -9.6% | -7.2% | +10.5% | |
| Q2 2023 | +7.5% | +10.5% | -4.2% | |
| Q1 2023 | +3.5% | +11.3% | -5.1% | |
| Q4 2022 | -16.4% | -20.9% | -35.2% | |
| Q3 2022 | -3.1% | -3.3% | -2.7% | |
| Q2 2022 | +10.4% | +4.3% | -8.7% | |
| Q1 2022 | -7.0% | -18.8% | +6.8% | |
| Q4 2021 | +10.7% | +8.0% | +39.7% | |
| Q3 2021 | +10.6% | +6.1% | -26.7% | |
| Q2 2021 | -8.5% | -4.8% | -11.2% | |
| Q1 2021 | +6.8% | +13.3% | +27.6% | |
| Q4 2020 | +6.8% | +13.3% | +27.6% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro